USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director Gilbert A. Fuller sold 490 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $44.59, for a total transaction of $21,849.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
USANA Health Sciences Price Performance
USANA Health Sciences stock opened at $45.07 on Thursday. The company’s 50-day moving average is $46.42 and its 200-day moving average is $48.05. The firm has a market capitalization of $865.34 million, a PE ratio of 14.04, a P/E/G ratio of 1.38 and a beta of 0.94. USANA Health Sciences, Inc. has a fifty-two week low of $41.45 and a fifty-two week high of $69.60.
USANA Health Sciences (NYSE:USNA – Get Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $221.08 million during the quarter, compared to the consensus estimate of $206.70 million. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.75 EPS for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several brokerages recently issued reports on USNA. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th. DA Davidson reduced their price target on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a report on Tuesday.
Get Our Latest Stock Report on USNA
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Tripe-Digit Growth Mid Cap Stocks to Watch This Quarter
- Overbought Stocks Explained: Should You Trade Them?
- Has FMC Stock Reached Bottom? First Quarter Earnings Say Yes
- Stock Dividend Cuts Happen Are You Ready?
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.